1,3-bis 2-chloroethyl-1-nitrosourea wafer(English)
- has not been proven to confer a significant advantage in survival for patients with grade III tumors when treated with the drug, compared with placebo
- CEAC, ICER, MGMT, QALY, TMZ
- Oncology, Therapeutic approaches
- https://doi.org/10.3310/hta11450